Diamonds and Dogs
7/26/13
Expedia Inc. (EXPE)Expedia is a bad trip for investors today, down 27.39% at $47.20. The online travel company saw its shares fall after a big miss on earnings for the second quarter. Expedia management announced an EPS of $0.64 on revenue of $1.21 billion. Wall Street analysts were expecting the company to earn $0.79 per share on revenue of $1.26 billion. The big missed caused analysts to cut their price targets for the company. Jefferies analyst, Brian Fitzgerald cut his target from $68 to $59. Expedia shares fell to a new 52-week low of $47.55 intraday.
Gentium S.p.A (GENT)
Gentium is trading in the green today, up 51.78% at $15.81. The biopharmaceutical company saw its shares skyrocket after news that it received positive opinion from the European Medicine's Agency (EMA). The positive opinion for Gentium's product, Defitelio, allows for a Marketing Authorization Application ("MAA") under exceptional circumstances, for the treatment of severe hepatic veno-occlusive disease ("VOD") in adults and children undergoing hematopoietic stem cell transplantation therapy. The positive opinion is a good sign for Gentium, however the European Commission will review the EMA's decision and has final authority. Gentium shares hit a new 52-week high of $15.90 intraday.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.